Genetic Assessment of the Patients With Metabolic Syndrome (GENMetS)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Medical Universtity of Lodz
ClinicalTrials.gov Identifier:
NCT01268696
First received: December 28, 2010
Last updated: July 20, 2011
Last verified: December 2010

December 28, 2010
July 20, 2011
December 2010
August 2011   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01268696 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Genetic Assessment of the Patients With Metabolic Syndrome
Genetic Assessment of the Patients With Metabolic Syndrome in Polish Population

Metabolic syndrome is a combination of medical disorders that increase the risk of developing cardiovascular disease and diabetes. The exact mechanisms of the complex pathways of metabolic syndrome are not yet completely known. The pathophysiology is extremely complex and has been only partially elucidated. Most patients are older, obese, sedentary, and have a degree of insulin resistance. Stress can also be a contributing factor. The most important factors are:

weight, genetics, aging, sedentary lifestyle,excess caloric intake. In our study we will assess the role of some polymorphisms in the pathology of metabolic syndrome.

Eligibility criteria to the study:

  • patients with metabolic syndrome
  • with written consent
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

the blood samples taken into EDTA

Probability Sample

Patients with metabolic syndrome

Metabolic Syndrome
Not Provided
  • control group
    healthy volunteers
  • Metabolic group
    Patients with metabolic syndrome
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
300
January 2015
August 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • patients with metabolic syndrome according to IDF,AHA and NHLBI 2009

Exclusion Criteria:

  • diabetes type 1
  • cancer
  • not consent
  • steroid therapy
  • alcohol or drug abuse
  • chronic inflammatory disease
  • pregnancy or lactation
  • severe hypothyroidism
  • immunosuppressive treatment
  • operation or severe injury during the last month
Both
18 Years to 80 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Poland
 
NCT01268696
RNN/202/10/KE
Yes
Department of Medical Biotechnology, Medical University of Lodz
Medical Universtity of Lodz
Not Provided
Study Chair: Tadeusz Pietrucha, prof. Department of medical biotechnology
Medical Universtity of Lodz
December 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP